We are excited to share the exciting news of the completion of our groundbreaking 12-month research pilot conducted in collaboration with Medic4all Italia, a prominent telemedicine provider. Throughout this pilot program, Ensofy's cutting-edge vocal biomarkers technology was tested on Medic4all's telehealth platform, with a specific focus on primary care patients. The innovative capabilities of this technology have showcased immense potential in revolutionizing mental health screening practices and ultimately enhancing patient outcomes.
The successful outcomes of this pilot have demonstrated the accuracy and effectiveness of our vocal biomarkers in identifying and screening major depressive disorder. This breakthrough not only validates the robustness of our technology but also signifies a significant milestone in the realm of mental health treatment.
Comments